{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:12:18Z","timestamp":1761999138780,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":233,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.idcr.2023.e01886","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:36:48Z","timestamp":1692758208000},"page":"e01886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["CNS tuberculoma in an immunocompetent patient: A case report of multi-drug hypersensitivity to RIPE therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Benjamin","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2023.e01886_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.15585\/mmwr.mm7112a1","article-title":"Tuberculosis \u2014 United States, 2021","volume":"71","author":"Filardo","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idcr.2023.e01886_bib3","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idcr.2023.e01886_bib4","doi-asserted-by":"crossref","unstructured":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. Vol. 161; 2000, p. S221\u201347. \u3008https:\/\/doi.org\/10.1164\/ajrccm.161.supplement_3.ats600\u3009.","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"10.1016\/j.idcr.2023.e01886_bib5","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1007\/s00415-022-11052-8","article-title":"Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis","volume":"269","author":"Navarro-Flores","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.idcr.2023.e01886_bib6","first-page":"5","article-title":"Central nervous system tuberculosis","author":"Leonard","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.idcr.2023.e01886_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9343(83)91011-2","article-title":"Intracranial tuberculoma: conservative management","volume":"74","author":"Harder","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.idcr.2023.e01886_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-510X(89)90046-4","article-title":"Tuberculosis of the nervous system. A clinical, radiological and pathological study of 39 consecutive cases in Riyadh, Saudi Arabia","volume":"90","author":"Bahemuka","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.idcr.2023.e01886_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/ijmy.ijmy_78_22","article-title":"Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug","volume":"11","author":"Katran","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.idcr.2023.e01886_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246291","article-title":"Hypersensitivity reactions to multiple anti-tuberculosis drugs","volume":"16","author":"Shin","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.idcr.2023.e01886_bib11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/thoraxjnl-2013-204503","article-title":"Incidence and risk factors for drug intolerance and association with incomplete treatment for tuberculosis: analysis of national case registers for England, Wales and Northern Ireland, 2001\u20132010","volume":"69","author":"Smith","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.idcr.2023.e01886_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/ecp.11.1","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls","volume":"4","author":"Dietrich","year":"2011","journal-title":"Expert Rev Clin Pharm"},{"key":"10.1016\/j.idcr.2023.e01886_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25333","article-title":"Global access of rifabutin for the treatment of tuberculosis \u2013 why should we prioritize this?","volume":"22","author":"Rockwood","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.idcr.2023.e01886_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/20009666.2018.1545516","article-title":"Successful rapid oral desensitization for dual hypersensitivity to isoniazid and rifampin while treating central nervous system tuberculosis","volume":"8","author":"Roy","year":"2018","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.idcr.2023.e01886_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4168\/aard.2013.1.4.395","article-title":"Successful desensitization for antitubercular drugs","volume":"1","author":"Lee","year":"2013","journal-title":"Allergy Asthma Respir Dis"},{"key":"10.1016\/j.idcr.2023.e01886_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13223-022-00737-4","article-title":"Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization","volume":"18","author":"Katran","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.idcr.2023.e01886_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaip.2019.06.009","article-title":"Multiple drug hypersensitivity syndrome in a large database","volume":"8","author":"Landry","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.idcr.2023.e01886_bib18","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","article-title":"Treatment of drug-resistant tuberculosis. An official ATS\/CDC\/ERS\/IDSA CLinical Practice Guideline","volume":"200","author":"Nahid","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idcr.2023.e01886_bib19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.idcr.2023.e01886_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2217\/fmb.12.86","article-title":"Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome","volume":"7","author":"Brancusi","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.idcr.2023.e01886_bib21","first-page":"3442","article-title":"Reintroduction of antituberculous drugs in patients with antituberculous drug-related drug reaction with eosinophilia and systemic symptoms","volume":"9","author":"Oh","year":"2021","journal-title":"J Allergy Clin Immunol: Pract"},{"key":"10.1016\/j.idcr.2023.e01886_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.rmed.2018.12.017","article-title":"Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications","volume":"147","author":"Ban","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.idcr.2023.e01886_bib23","unstructured":"WHO consolidated guidelines on tuberculosis: module 4: treatment \u2013 drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020."},{"key":"10.1016\/j.idcr.2023.e01886_bib24","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1164\/rccm.202107-1779OC","article-title":"An all-oral 6-month regimen for multidrug-resistant tuberculosis: a multicenter, randomized controlled clinical trial (the NExT study)","volume":"205","author":"Esmail","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idcr.2023.e01886_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0300-2977(00)00100-5","article-title":"Repeatedly negative tuberculin skin tests followed by active tuberculosis in an immunocompetent individual","volume":"58","author":"Arend","year":"2001","journal-title":"Neth J Med"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092300210X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092300210X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:07:49Z","timestamp":1761998869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221425092300210X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":24,"alternative-id":["S221425092300210X"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01886","relation":{},"ISSN":["2214-2509"],"issn-type":[{"type":"print","value":"2214-2509"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNS tuberculoma in an immunocompetent patient: A case report of multi-drug hypersensitivity to RIPE therapy","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01886"}}